Skip to main content
. 2009 Jul 22;114(13):2598–2605. doi: 10.1182/blood-2008-08-173674

Figure 2.

Figure 2

The presence of a kinase domain mutation predicts shorter progression-free survival after sequencing. The cumulative rate of progression-free survival (Kaplan-Meier method) is shown for patients with, versus patients without, a detectable KD mutation.